Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NECTAR: Aluvra for GERD
NCT03090607Unknown
- Sponsor
- Impleo Medical
- Start
- Nov 2017
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Randomised, double-blind trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Impleo Medical. Primary endpoints: GERD-Health Related Quality of Life at 12 months and Esophageal pH at 12 months. Status: unknown.
02
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03090607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090607.